ID   HTh112
AC   CVCL_A428
SY   HTh 112; HTh-112; Uhth-112; U-hth112; U-Hth112
DR   Cosmic; 1068621
DR   Cosmic; 1239972
DR   Cosmic; 2050369
DR   Wikidata; Q54896654
RX   PubMed=17465858;
RX   PubMed=21868764;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17465858; PubMed=21868764
ST   Amelogenin: X (PubMed=21868764)
ST   Amelogenin: X,Y (PubMed=17465858)
ST   CSF1PO: 12
ST   D13S317: 11 (PubMed=21868764)
ST   D13S317: 12 (PubMed=17465858)
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 31
ST   D3S1358: 15,18
ST   D5S818: 11 (PubMed=21868764)
ST   D5S818: 12 (PubMed=17465858)
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 19 (PubMed=21868764)
ST   vWA: 20 (PubMed=17465858)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 15
//
RX   PubMed=17465858; DOI=10.1089/thy.2006.0246;
RA   Lee J.-J., Foukakis T., Hashemi J., Grimelius L., Heldin N.-E.,
RA   Wallin G., Rudduck C., Lui W.-O., Hoog A., Larsson C.;
RT   "Molecular cytogenetic profiles of novel and established human
RT   anaplastic thyroid carcinoma models.";
RL   Thyroid 17:289-301(2007).
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//